Evaxion Biotech A/S

Filed a patent for "method for predicting response to cancer immunotherapy" on Fri, January 5, 2024

Filed a patent for "vaccines targeting neisseria gonorrhoeae" on Fri, January 5, 2024

Filed a patent for "peptides derived from acinetobacter baumannii and their use in vaccination" on Thu, July 11, 2024

Filed a patent for "proteins and nucleic acids useful in vaccines targeting staphylococcus aureus" on Thu, April 25, 2024

Filed a patent for "nucleic acid vaccination using neo-epitope encoding constructs" on Thu, March 9, 2023

Filed a patent for "vaccines targeting neisseria gonorrhoeae" on Thu, February 16, 2023

Filed a patent for "chimeric proteins for inducing immunity towards infection with s. aureus" on Thu, February 9, 2023

Filed a patent for "neoepitope immunotherapy with apc targeting unit" on Thu, May 11, 2023